Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Johnson & Johnson MedTech has launched a new next-generation catheter to be used when treating acute ischemic stroke patients. The Cereglide 92 Catheter System includes a 0.92” catheter as well as the company’s Innerglide 9 deliver aid.

Johnson & Johnson MedTech launches new large-bore catheter system for stroke

The next-generation catheter was designed to help clinicians restore blood flow safely and effectively after patients have experienced an acute ischemic stroke. 

doctor wrong patient wrong-site surgery medical error malpractice mistake

Use of biolimus-coated balloons during PCI not as effective as paclitaxel devices

Researchers tracked data from more than 200 patients who underwent PCI from August 2020 to July 2022, sharing their findings in JACC: Cardiovascular Interventions.

artificial intelligence money finance acquisition

Report: Johnson & Johnson wants to sell its stroke business for more than $1B

Johnson & Johnson has reportedly had early discussions with potential buyers about its Cerenovus division of stroke products.

Thumbnail

MRI study suggests an optimal time of day for evaluating glymphatic function

Inaccurate interpretations of glymphatic function could lead to incorrect diagnoses, researchers caution.

female cardiologist

Interventional heart failure: An evolving cardiology subspecialty with a bright future

IHF cardiologists can come from a variety of backgrounds, but they all share the same goal: to ensure complex heart failure patients receive the best care possible. 

20-minute ultrasound-guided procedure could cure hypertension

Hypertension caused by unilateral aldosterone-producing adrenal adenomas is curable by laparoscopic removal of the entire adrenal gland, but the invasiveness and recovery time can deter patients from the treatment.

healthcare money economics dollar stethoscope acquire merger

Novartis to acquire drugmaker behind new heart therapy for up to $3.1B

The FDA has already shown great interest in the drug, which is designed to help AFib patients reduce their stroke and systemic embolism risks.

Cardiologist heart

Treating a broken heart: Beta-blockers improve survival in patients with takotsubo syndrome

Takotsubo syndrome, commonly known as “broken heart syndrome,” is often treated as if it was heart failure, but the optimal clinical approach remains a bit of a mystery.